Sobel R A, Hanzakos J L, Blanchette B W, Williams A M, Dellapelle P, Colvin R B
J Immunol. 1987 Apr 15;138(8):2500-6.
As part of a study of the therapeutic potential of anti-T cell monoclonal antibodies, we studied the biologic effects of 8BE6, a mouse anti-guinea pig (GP) pan-T cell monoclonal antibody, on blood and tissue T cells and on the prototypic T cell-mediated reactions, classic delayed hypersensitivity (DH) and cutaneous basophil hypersensitivity (CBH). 8BE6 reacts to a 68,000 m.w. protein probably homologous with human CD5 (T1) and murine Lyt-1. A single dose of 1.8 to 3.4 mg 8BE6 caused lymphopenia and greater than 90% depletion of 8BE6+ peripheral T cells 1 to 72 hr later, and a significant but lesser decrease of lymphocytes reacting with another pan-T cell monoclonal antibody (p less than 0.02 at 24 hr). Free serum 8BE6 was detected for up to 48 hr after administration. Immunoperoxidase stains of tissue revealed that lymphocytes in lymph nodes and spleen were coated with mouse immunoglobulin 1 hr after antibody treatment and displayed in situ capping. Subsequently, there was a loss of T cells in all tissues (spleen, lymph node, liver, and kidney) except the thymus, with normal 8BE6 antigen staining returning by 72 hr. Areas of induration of DH reactions to PPD were reduced in 8BE6-treated GP, compared with pretreatment reactions in the same GP or in control-treated GP (p less than 0.001 for both). The numbers of infiltrating T cells and fibronectin-receptor-positive macrophages were also reduced. In contrast, 8BE6 had no effect on CBH reactions, as judged by erythema and basophil counts in 1-micron sections, although fewer T cells were found in reaction sites. There were no differences in IgM, fibronectin, or Ia staining between 8BE6-treated GP and controls. In vivo administration of a single dose of anti-T cell monoclonal antibody results in a transient, highly specific depletion of T cell populations in peripheral blood and tissues except the thymus. This treatment inhibits DH but not CBH reactions by systemic and local depletion of T cells.
作为抗T细胞单克隆抗体治疗潜力研究的一部分,我们研究了小鼠抗豚鼠(GP)全T细胞单克隆抗体8BE6对血液和组织T细胞以及对典型的T细胞介导反应(经典迟发型超敏反应(DH)和皮肤嗜碱性粒细胞超敏反应(CBH))的生物学效应。8BE6与一种分子量为68,000的蛋白质反应,该蛋白质可能与人CD5(T1)和小鼠Lyt-1同源。单次剂量1.8至3.4mg的8BE6在1至72小时后导致淋巴细胞减少以及8BE6 +外周T细胞减少超过90%,并且与另一种全T细胞单克隆抗体反应的淋巴细胞有显著但较小程度的减少(24小时时p<0.02)。给药后长达48小时可检测到游离血清8BE6。组织的免疫过氧化物酶染色显示,抗体处理1小时后,淋巴结和脾脏中的淋巴细胞被小鼠免疫球蛋白包被并呈现原位帽化。随后,除胸腺外,所有组织(脾脏、淋巴结、肝脏和肾脏)中的T细胞均减少,到72小时时8BE6抗原染色恢复正常。与相同豚鼠的预处理反应或对照处理的豚鼠相比,8BE6处理的豚鼠对PPD的DH反应硬结面积减小(两者p均小于0.001)。浸润的T细胞和纤连蛋白受体阳性巨噬细胞数量也减少。相比之下,从1微米切片中的红斑和嗜碱性粒细胞计数判断,8BE6对CBH反应没有影响,尽管在反应部位发现的T细胞较少。8BE6处理的豚鼠和对照之间在IgM、纤连蛋白或Ia染色方面没有差异。体内单次给予抗T细胞单克隆抗体导致外周血和除胸腺外的组织中的T细胞群体出现短暂、高度特异性的耗竭。这种治疗通过全身和局部耗竭T细胞来抑制DH反应,但不抑制CBH反应。